Evidence map›Paper›PMID 30587795›Full record

ArticleInternational journal of molecular sciences2018

LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of Apoptosis and Necroptosis.

Patricia Masso-Welch, Sofia Girald Berlingeri, Natalie D King-Lyons, Lorrie Mandell, John Hu, Christopher J Greene, Matthew Federowicz, Peter Cao, Terry D Connell, Yasser Heakal

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. EnterotoxigenicGut microbes
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Patricia Masso-WelchDepartment of Biotechnical and Clinical Laboratory Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 3435 Main Street, Buffalo, NY 14214, USA. pmwelch@buffalo.edu.
Sofia Girald BerlingeriDepartment of Biotechnical and Clinical Laboratory Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 3435 Main Street, Buffalo, NY 14214, USA. sofia.girald@upr.edu.
Natalie D King-LyonsDepartment of Microbiology and Immunology and the Witebsky Center for Microbial Pathogenesis and Immunology, Jacobs School of Medicine and Biomedical Sciences, The University at Buffalo, 955 Main Street, Buffalo, NY 14203, USA. ndking@buffalo.edu.
Lorrie MandellDepartment of Microbiology and Immunology and the Witebsky Center for Microbial Pathogenesis and Immunology, Jacobs School of Medicine and Biomedical Sciences, The University at Buffalo, 955 Main Street, Buffalo, NY 14203, USA. lmc29@buffalo.edu.
John HuDepartment of Microbiology and Immunology and the Witebsky Center for Microbial Pathogenesis and Immunology, Jacobs School of Medicine and Biomedical Sciences, The University at Buffalo, 955 Main Street, Buffalo, NY 14203, USA. conghu@buffalo.edu.
Christopher J GreeneDepartment of Microbiology and Immunology and the Witebsky Center for Microbial Pathogenesis and Immunology, Jacobs School of Medicine and Biomedical Sciences, The University at Buffalo, 955 Main Street, Buffalo, NY 14203, USA. christopher.greene@roswellpark.org.
Matthew FederowiczDepartment of Pharmaceutical, Social and Administrative Sciences, School of Pharmacy, D'Youville College, 320 Porter Avenue, Buffalo, NY 14201, USA. federm07@dyc.edu.
Peter CaoDepartment of Pharmaceutical, Social and Administrative Sciences, School of Pharmacy, D'Youville College, 320 Porter Avenue, Buffalo, NY 14201, USA. caop13@dyc.edu.
Terry D ConnellDepartment of Microbiology and Immunology and the Witebsky Center for Microbial Pathogenesis and Immunology, Jacobs School of Medicine and Biomedical Sciences, The University at Buffalo, 955 Main Street, Buffalo, NY 14203, USA. connell@buffalo.edu.
Yasser HeakalDepartment of Pharmaceutical, Social and Administrative Sciences, School of Pharmacy, D'Youville College, 320 Porter Avenue, Buffalo, NY 14201, USA. heakaly@dyc.edu.
University at Buffalo, State University of New York · USD'Youville College · US

Funding

Specific induction of lethal autophagy in triple-negative breast cancer cellsR21CA208475 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI CONNELL, TERRY D. · 2017 to 2018
$385k
D'Youville School of Pharmacy NANational Cancer Institute 1 R21 CA208475-Terry D. Connell (PI); Patricia Masso-Welch (Co-I); Yasser Heakel (Co-I)
6 · The paper itself

Abstract

Triple negative breast cancer (TNBC) remains a serious health problem with poor prognosis and limited therapeutic options. To discover novel approaches to treat TNBC, we screened cholera toxin (CT) and the members of the bacterial type II heat-labile enterotoxin family (LT-IIa, LT-IIb, and LT-IIc) for cytotoxicity in TNBC cells. Only LT-IIc significantly reduced viability of the TNBC cell lines BT549 and MDA-MB-231 (IC

Indexed as

ApoptosisAutophagyAutophagy-Related Protein 5Caspase 3Cell Line, TumorCell SurvivalEnterotoxinsFemaleHot TemperatureHumansImidazolesIndolesLysosomesNecrosisRNA-Binding ProteinsRNA InterferenceAutophagy-Related Protein 5Caspase 3EnterotoxinsImidazolesIndolesMTOR protein, humannecrostatin-1P62 protein, humanRNA-Binding ProteinsRNA, Small InterferingTOR Serine-Threonine Kinasesapoptosisautophagybacterial enterotoxinsbreast cancerheat-labile enterotoxinsLT-IIcnecroptosistriple-negative breast cancer

Identifiers

PMID30587795
PMCPMC6337683
OpenAlexW2905745154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.